Zoetis raises $2.2bn in IPO but other pharma majors to retain animal health
This article was originally published in Scrip
Executive Summary
Pfizer's animal health spinout Zoetis priced its initial public offering at $26 per share late 31 January - $1 above the previously announced range of $22 to $25 - to raise $2.2 billion from the sale of 86.1 million shares.